After adjusting for age, gender, WHO functional classes, NT-proBNP, mPAP, absence of targeted therapy, and other hemodynamics, hyperuricemia also remained significantly associated with 5-year mortality (HR 2.61, 95% CI 1.02–6.68, p = 0.046) (Table 3). This evidence concerns the gene NPPB and hyperuricemia.